Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Koninklijke Philips NV (PHG) Price & Performance

Abeona Therapeutics IncTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Koninklijke Philips NV — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Koninklijke Philips NV trades at $26.99 (market cap $26.58B). The key difference: Koninklijke Philips NV is far larger — about 63.1× Abeona Therapeutics Inc's market cap, and Koninklijke Philips NV pays a 3.75% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

ABEOPHG
Market Cap
$421.19M$26.58B
Sector
HealthHealth
52-Week High
$7.45$32.91
52-Week Low
$4.17$25.02
Enterprise Value
$276.10M$33.13B
Dividend Yield
3.75%

Returns comparison

Trailing returns across standard periods

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG